OA09250A - "New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome". - Google Patents
"New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome".Info
- Publication number
- OA09250A OA09250A OA59701A OA59701A OA09250A OA 09250 A OA09250 A OA 09250A OA 59701 A OA59701 A OA 59701A OA 59701 A OA59701 A OA 59701A OA 09250 A OA09250 A OA 09250A
- Authority
- OA
- OAPI
- Prior art keywords
- new
- leukocytes
- regeneration
- ensuring
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR888816749A FR2640508B1 (en) | 1988-12-19 | 1988-12-19 | NOVEL COMPOSITIONS AND NEW PHARMACEUTICAL PRODUCTS ENSURING THE REGENERATION OF LEUKOCYTES AND THEIR USE FOR THE TREATMENT OF IMMUNE DEFICIT SYNDROME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09250A true OA09250A (en) | 1992-06-30 |
Family
ID=9373109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59701A OA09250A (en) | 1988-12-19 | 1989-12-19 | "New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome". |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0375471B1 (en) |
| JP (1) | JPH02258722A (en) |
| KR (1) | KR900009075A (en) |
| AP (1) | AP125A (en) |
| AT (1) | ATE136463T1 (en) |
| AU (2) | AU4686189A (en) |
| CA (1) | CA2005925C (en) |
| DE (1) | DE68926222D1 (en) |
| DK (1) | DK646489A (en) |
| FR (1) | FR2640508B1 (en) |
| HU (1) | HU213510B (en) |
| IL (1) | IL92759A (en) |
| MA (1) | MA21964A1 (en) |
| MY (1) | MY106032A (en) |
| NZ (1) | NZ231854A (en) |
| OA (1) | OA09250A (en) |
| PT (1) | PT92620B (en) |
| TN (1) | TNSN89135A1 (en) |
| ZA (1) | ZA899733B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5155226A (en) * | 1991-02-19 | 1992-10-13 | Hoechst-Roussel Pharmaceuticals Incorporated | Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine |
| EP0509401A1 (en) * | 1991-04-19 | 1992-10-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids |
| RU2036198C1 (en) * | 1993-04-01 | 1995-05-27 | Товарищество с ограниченной ответственностью "Полисан" | N-METHYL- N- (α-D- GLUCOPYRANOSYL) -AMMONIUM -2-(ACRIDONE -9-ONE -10-YL) -ACETATE (CYCLOFERON) SHOWING INTERFEROGENIC, ANTIVIRAL AMONG THEM ANTI-HIV, ANTIPARASITIC, ANTIPROMOTER AND RADIOPROTECTIVE ACTIVITIES |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4916122A (en) * | 1987-01-28 | 1990-04-10 | University Of Georgia Research Foundation, Inc. | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition |
| EP0332626A1 (en) * | 1986-11-21 | 1989-09-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Compositions for treating viral infections in humans |
| IL86009A (en) * | 1987-04-10 | 1991-09-16 | Us Health | Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases |
| US5013741A (en) * | 1987-09-08 | 1991-05-07 | Hoechst-Roussel Pharmaceuticals Incorporated | N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal |
| US4985430A (en) * | 1987-12-03 | 1991-01-15 | Mitsubishi Kasei Corporation | 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient |
| CH678275A5 (en) * | 1989-05-25 | 1991-08-30 | Debiopharm Sa | |
| US4999358A (en) * | 1989-06-26 | 1991-03-12 | Hoechst-Roussel Pharmaceuticals Inc. | (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds |
| US4999430A (en) * | 1989-07-31 | 1991-03-12 | Warner-Lambert Company | Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine |
-
1988
- 1988-12-19 FR FR888816749A patent/FR2640508B1/en not_active Expired - Fee Related
-
1989
- 1989-09-29 EP EP89402687A patent/EP0375471B1/en not_active Expired - Lifetime
- 1989-09-29 AT AT89402687T patent/ATE136463T1/en not_active IP Right Cessation
- 1989-09-29 DE DE68926222T patent/DE68926222D1/en not_active Expired - Lifetime
- 1989-12-18 AP APAP/P/1990/000157A patent/AP125A/en active
- 1989-12-18 MY MYPI89001798A patent/MY106032A/en unknown
- 1989-12-18 IL IL9275989A patent/IL92759A/en not_active IP Right Cessation
- 1989-12-18 MA MA21958A patent/MA21964A1/en unknown
- 1989-12-19 JP JP1329377A patent/JPH02258722A/en active Pending
- 1989-12-19 ZA ZA899733A patent/ZA899733B/en unknown
- 1989-12-19 CA CA002005925A patent/CA2005925C/en not_active Expired - Fee Related
- 1989-12-19 AU AU46861/89A patent/AU4686189A/en not_active Abandoned
- 1989-12-19 PT PT92620A patent/PT92620B/en not_active IP Right Cessation
- 1989-12-19 HU HU896683A patent/HU213510B/en not_active IP Right Cessation
- 1989-12-19 NZ NZ231854A patent/NZ231854A/en unknown
- 1989-12-19 OA OA59701A patent/OA09250A/en unknown
- 1989-12-19 TN TNTNSN89135A patent/TNSN89135A1/en unknown
- 1989-12-19 DK DK646489A patent/DK646489A/en not_active Application Discontinuation
- 1989-12-19 KR KR1019890019125A patent/KR900009075A/en not_active Ceased
-
1993
- 1993-05-25 AU AU39806/93A patent/AU666725B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MY106032A (en) | 1995-02-28 |
| CA2005925C (en) | 2002-03-26 |
| DE68926222D1 (en) | 1996-05-15 |
| HU213510B (en) | 1997-07-28 |
| EP0375471A3 (en) | 1992-07-08 |
| AP8900157A0 (en) | 1990-01-31 |
| AP125A (en) | 1991-03-19 |
| EP0375471A2 (en) | 1990-06-27 |
| AU666725B2 (en) | 1996-02-22 |
| ZA899733B (en) | 1991-04-24 |
| ATE136463T1 (en) | 1996-04-15 |
| CA2005925A1 (en) | 1990-06-19 |
| PT92620A (en) | 1990-06-29 |
| IL92759A0 (en) | 1990-09-17 |
| TNSN89135A1 (en) | 1991-02-04 |
| HU896683D0 (en) | 1990-02-28 |
| FR2640508B1 (en) | 1994-07-01 |
| EP0375471B1 (en) | 1996-04-10 |
| JPH02258722A (en) | 1990-10-19 |
| AU3980693A (en) | 1993-08-19 |
| DK646489D0 (en) | 1989-12-19 |
| FR2640508A1 (en) | 1990-06-22 |
| MA21964A1 (en) | 1991-07-01 |
| PT92620B (en) | 1995-09-12 |
| NZ231854A (en) | 1993-01-27 |
| KR900009075A (en) | 1990-07-02 |
| AU4686189A (en) | 1990-06-21 |
| IL92759A (en) | 1994-06-24 |
| DK646489A (en) | 1990-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0605024A3 (en) | Use of purified surface modifiers to avoid aggregation of particles during sterilization. | |
| MA21129A1 (en) | AN IMPACT MODIFIER IN THE USE OF SMOKING ARTICLES | |
| OA08617A (en) | Neutral metalloendopeptidase inhibitors in the treatment of hypertention. | |
| EP0270690A4 (en) | MEDICINE FOR THE TREATMENT AND PROPHYLAXIS OF KIDNEY AND LIVER DISEASES. | |
| FR2462167B1 (en) | INTERFERON OF HUMAN FIBROPLASTS IN THE FORM OF A HOMOGENEOUS PROTEIN AND ITS PREPARATION | |
| OA07925A (en) | Food product effective in the treatment of leprosy. | |
| FR2455572B1 (en) | PHENYLETHYLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS, AND COMPOSITIONS CONTAINING THEM | |
| FR2717080B1 (en) | Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases. | |
| ATE67783T1 (en) | HOMOGENEOUS RECOMBINANT IMMUNE INTERFERON FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| OA09250A (en) | "New compositions and new pharmaceuticals ensuring the regeneration of leukocytes and their use in the treatment of immune deficiency syndrome". | |
| IT8619032A0 (en) | IMPROVEMENTS MADE TO THE TREATMENT OF PARTICULATE MATERIALS. | |
| FR2612775B1 (en) | COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SKIN DEGENERATION | |
| IT1234230B (en) | Camphor benzylidene sulphonamides deriving from amino acids and their use in cosmetics particularly as solar filters | |
| FI922428A0 (en) | NYA 2-AMINO-5-CYAN-1,4-DIHYDROPYRIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL. | |
| FR2584074B1 (en) | 5,6-EPOXY-7-OXABICYCLOHEPTANE ETHERS USEFUL IN THE TREATMENT OF THROMBOSES | |
| FR2684552B1 (en) | USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS. | |
| DE3886371D1 (en) | MANUFACTURE OF HBLV VIRUS IN THE HSB-2 CELL LINE. | |
| FR2724935B1 (en) | NANOPARTICLE COMPOSITIONS CONTAINING NUCLEOTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS | |
| FR2511597B1 (en) | PRODUCTS EXTRACTED FROM MARINE INVERTEBERS, THEIR PREPARATION AND THEIR APPLICATIONS IN DIETETICS AND COSMETOLOGY | |
| FR2663539B1 (en) | USE OF D-FENFLURAMINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF IMMUNE DEFICIENCIES IN THE AGED SUBJECT. | |
| FR2505825B1 (en) | ISOPRENYLAMINE DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | |
| FR2709964B1 (en) | Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes. | |
| FR2542744B2 (en) | 3 ', 5'-DIARABINOSIDES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS | |
| EP0655919A4 (en) | TREATMENT OF VIRAL INFECTIONS IN MAN. | |
| EP0871472A4 (en) | CYTOKINES AND THEIR USE IN THE TREATMENT AND / OR PROPHYLAXIS OF BREAST CANCER |